Basel is the early corporate centre of Jack Harkness’s pharmaceutical career and a lingering production base for Harkness Pharmaceuticals. Its importance is both institutional and investigative: the city marks the company’s origins before its headquarters move to Zug, while its proximity to Lausanne gives Gareth Lawler a possible, but unconfirmed, connection between Jane Glasson and Harkness’s business.

Corporate beginnings

After an unexplained period away from public view, Harkness appears in Switzerland as personal assistant to Lenore Furgler, whose family company was based in Basel. During the 1980s he gains a place on the company board and responsibility for strategy. The account establishes Basel as the setting of his entry into the pharmaceutical business, though it does not describe particular scenes or operations in the city.

In 1995, as Furgler’s health declined, she sold the company to Harkness. The sale was not at a premium price, and the source of Harkness’s money remained uncertain; rumours suggested that he had borrowed from Vladimir Drishkov. The change of ownership was decisive: the company was renamed Harkness Pharmaceuticals, placing Basel at the start of the corporate history behind Harkness’s later wealth and influence.

Headquarters and production

Harkness Pharmaceuticals grew rapidly under its new owner. The company established a research laboratory in Locarno, where Filippo Crosetti developed beauty products that helped make it internationally prominent, culminating in Elixtris. Around the product’s 2009 release, Harkness moved the company headquarters from Basel to Zug, a canton Clarice Dow describes as having Switzerland’s lowest taxes. Basel nevertheless remained the centre of production. The transfer therefore changed the company’s administrative address without removing the city from its industrial structure.

The relocation also forms part of the account of Harkness’s financial strategy. Clarice says that he arranged for much of his personal salary to pass through Liechtenstein, while the headquarters sat in Zug and production remained concentrated in Basel. These details situate the city within a dispersed corporate arrangement rather than presenting it as the company’s sole centre. They also help explain why the investigation distinguishes between the company’s registered or administrative base and where its products were made.

A possible link to Jane Glasson

Basel enters the search for Jane through Gareth’s recollection of a journey with her. On the way back from a trip to Italy, Jane left him at Lausanne to visit a school friend in Switzerland. Harkness Pharmaceuticals was still headquartered in Basel at the time, and Gareth later noted that the cities were only a couple of hours apart by train. He had not connected the visit to the company then; after recognizing the company logo on a screen Jane had used at Paddington, he began to wonder whether her Swiss stop had been related to Harkness.

The connection remains a hypothesis, not a confirmed meeting or destination. Jane did not tell Gareth who the friend was, and his recollection supplies no evidence that she travelled on to Basel. The city’s importance in this strand comes from the way separate clues accumulate: a concealed Swiss visit, the company logo, and Basel’s then-current place in Harkness Pharmaceuticals’ history. The uncertainty keeps the location useful to the investigation without resolving Jane’s reasons for going to Switzerland.

Narrative significance

Basel links Harkness’s personal ascent to the institutional history of his company, then persists as a clue after its headquarters move. It also gives the investigation a concrete geographic point against which Gareth can reconsider Jane’s movements. Yet the novel keeps the distinction between proximity and proof: Basel makes a connection plausible, while the evidence presented does not establish that Jane went there or explain what she may have done in Switzerland.